United States (US) Antivirals Market (2025-2031) | Segmentation, Growth, Competitive Landscape, Forecast, Outlook, Companies, Size & Revenue, Analysis, Share, Trends, Industry, Value

Name: United States (US) Antivirals Market (2025-2031) | Segmentation & Growth
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy
Keywords: Antivirals Market, United States (US) Antivirals Market, United States (US) Antivirals Market Revenues, United States (US) Antivirals Market Share, United States (US) Antivirals Market Size, United States (US) Antivirals Market Outlook, United States (US) Antivirals Market Report, United States (US) Antivirals Market Competition, United States (US) Antivirals Market Overview, United States (US) Antivirals Market Trends, United States (US) Antivirals Market Forecast

Market Forecast By Type (Hepatitis-C antivirals, HIV antivirals, Herpes antivirals, Hepatitis-B antivirals, Influenza antivirals, Others), By Actions (DNA polymerase inhibitors, NS3 Protease inhibitors, Reverse transcriptase inhibitors, Others) And Competitive Landscape

Product Code: ETC9959373	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Sumit Sagar	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Antivirals Market Outlook
Market Size of United States (US) Antivirals Market, 2024
Forecast of United States (US) Antivirals Market, 2031
Historical Data and Forecast of United States (US) Antivirals Revenues & Volume for the Period 2021- 2031
United States (US) Antivirals Market Trend Evolution
United States (US) Antivirals Market Drivers and Challenges
United States (US) Antivirals Price Trends
United States (US) Antivirals Porter's Five Forces
United States (US) Antivirals Industry Life Cycle
Historical Data and Forecast of United States (US) Antivirals Market Revenues & Volume By Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antivirals Market Revenues & Volume By Hepatitis-C antivirals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antivirals Market Revenues & Volume By HIV antivirals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antivirals Market Revenues & Volume By Herpes antivirals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antivirals Market Revenues & Volume By Hepatitis-B antivirals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antivirals Market Revenues & Volume By Influenza antivirals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antivirals Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antivirals Market Revenues & Volume By Actions for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antivirals Market Revenues & Volume By DNA polymerase inhibitors for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antivirals Market Revenues & Volume By NS3 Protease inhibitors for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antivirals Market Revenues & Volume By Reverse transcriptase inhibitors for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antivirals Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) Antivirals Import Export Trade Statistics
Market Opportunity Assessment By Type
Market Opportunity Assessment By Actions
United States (US) Antivirals Top Companies Market Share
United States (US) Antivirals Competitive Benchmarking By Technical and Operational Parameters
United States (US) Antivirals Company Profiles
United States (US) Antivirals Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Antivirals Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Antivirals Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Antivirals Market - Industry Life Cycle

3.4 United States (US) Antivirals Market - Porter's Five Forces

3.5 United States (US) Antivirals Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Antivirals Market Revenues & Volume Share, By Actions, 2021 & 2031F

4 United States (US) Antivirals Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of viral infections in the United States

4.2.2 Technological advancements in antiviral drug development

4.2.3 Growing awareness about the importance of antiviral medications

4.3 Market Restraints

4.3.1 High cost associated with antiviral drugs

4.3.2 Stringent regulatory requirements for drug approval

4.3.3 Competition from alternative treatments such as vaccines and natural remedies

5 United States (US) Antivirals Market Trends

6 United States (US) Antivirals Market, By Types

6.1 United States (US) Antivirals Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Antivirals Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Antivirals Market Revenues & Volume, By Hepatitis-C antivirals, 2021- 2031F

6.1.4 United States (US) Antivirals Market Revenues & Volume, By HIV antivirals, 2021- 2031F

6.1.5 United States (US) Antivirals Market Revenues & Volume, By Herpes antivirals, 2021- 2031F

6.1.6 United States (US) Antivirals Market Revenues & Volume, By Hepatitis-B antivirals, 2021- 2031F

6.1.7 United States (US) Antivirals Market Revenues & Volume, By Influenza antivirals, 2021- 2031F

6.1.8 United States (US) Antivirals Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Antivirals Market, By Actions

6.2.1 Overview and Analysis

6.2.2 United States (US) Antivirals Market Revenues & Volume, By DNA polymerase inhibitors, 2021- 2031F

6.2.3 United States (US) Antivirals Market Revenues & Volume, By NS3 Protease inhibitors, 2021- 2031F

6.2.4 United States (US) Antivirals Market Revenues & Volume, By Reverse transcriptase inhibitors, 2021- 2031F

6.2.5 United States (US) Antivirals Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Antivirals Market Import-Export Trade Statistics

7.1 United States (US) Antivirals Market Export to Major Countries

7.2 United States (US) Antivirals Market Imports from Major Countries

8 United States (US) Antivirals Market Key Performance Indicators

8.1 Research and development investment in new antiviral drugs

8.2 Number of FDA approvals for antiviral medications

8.3 Patient adherence to antiviral treatment regimens

8.4 Rate of adoption of antiviral drugs by healthcare providers

9 United States (US) Antivirals Market - Opportunity Assessment

9.1 United States (US) Antivirals Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Antivirals Market Opportunity Assessment, By Actions, 2021 & 2031F

10 United States (US) Antivirals Market - Competitive Landscape

10.1 United States (US) Antivirals Market Revenue Share, By Companies, 2024

10.2 United States (US) Antivirals Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Antivirals Market

El Salvador Antivirals Market

Equatorial Guinea Antivirals Market

Eritrea Antivirals Market

Estonia Antivirals Market

Ethiopia Antivirals Market

Global Antivirals Market

Middle East Antivirals Market

North America Antivirals Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here